Organization profile
Organization profile
The Skaggs School of Pharmacy at the University of Montana is the state’s only pharmacy school, with a rich history dating back to 1907. Located within the College of Health, it offers a Doctor of Pharmacy (Pharm.D.) program alongside graduate degrees in toxicology, medicinal chemistry, pharmaceutical sciences, and dual-degree options that integrate pharmacy with public health, business, and research. The School’s two departments—Pharmacy Practice and Biomedical and Pharmaceutical Sciences—provide a comprehensive education combining rigorous basic science with extensive clinical and interprofessional experiences. Through early and progressive hands-on training, outreach programs, and a commitment to serving rural and underserved communities, Skaggs prepares pharmacists to be compassionate, skilled healthcare professionals ready to meet diverse healthcare needs across Montana and beyond.
Fingerprint
Collaborations and top research areas from the last five years
Profiles
-
Walid Abdelwahab
- Biomedical and Pharmaceutical Sciences - Research Assistant Professor
- Center for Translational Medicine - Affiliate
Person
-
-
-
ASHP and ASHP Foundation Pharmacy Forecast 2026: Strategic Planning Guidance for Pharmacy Departments in Hospitals and Health Systems
DiPiro, J. T., Couldry, R., Dopp, A. L., Kraus, T., Vest, T. A., Chou, J., Watanabe, J. H., Fretland, K., Fabian, T. J., Gosser, R., Blind, J. E., Blackburn, H., Gruenberg, K., Merandi, J., Cunningham, F. E. & Hoffman, J. M., Jan 15 2026, In: American Journal of Health-System Pharmacy. 83, 2, p. 71-101 31 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Air pollution is a major risk factor for the development of Alzheimer's disease, cognition deficits, systemic and neural inflammation in urban children
Calderón-Garcidueñas, L., Jun 2025, In: The Lancet Regional Health - Americas. 46, 101129.Research output: Contribution to journal › Letter › peer-review
Open Access -
Alzheimer’s, Parkinson’s, Frontotemporal Lobar Degeneration, and Amyotrophic Lateral Sclerosis Start in Pediatric Ages: Ultrafine Particulate Matter and Industrial Nanoparticles Are Key in the Early-Onset Neurodegeneration: Time to Invest in Preventive Medicine
Calderón-Garcidueñas, L., González-Maciel, A., Reynoso-Robles, R., Cejudo-Ruiz, F. R., Silva-Pereyra, H. G., Gorzalski, A. & Torres-Jardón, R., Mar 2025, In: Toxics. 13, 3, 178.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations